These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8869473

  • 1. Induction of tolerance using porcine factor VIII.
    Hay CR, Laurian Y.
    Vox Sang; 1996; 70 Suppl 1():68-9. PubMed ID: 8869473
    [No Abstract] [Full Text] [Related]

  • 2. Induction of immune tolerance with factor VIII concentrate in patients with hemophilia A and inhibitors.
    Ewing NP.
    Prog Clin Biol Res; 1990; 324():59-68. PubMed ID: 2106693
    [No Abstract] [Full Text] [Related]

  • 3. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
    White GC, Greenwood R, Escobar M, Frelinger JA.
    Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
    [Abstract] [Full Text] [Related]

  • 4. Immunological and laboratory aspects of immune tolerance.
    Kazatchkine M, Hoyer L.
    Vox Sang; 1996 Oct; 70 Suppl 1():52-9. PubMed ID: 8869470
    [No Abstract] [Full Text] [Related]

  • 5. [Porcine factor VIII].
    De Juan MJ, Montoro JB, Tusell JM.
    Sangre (Barc); 1991 Jun; 36(3):217-20. PubMed ID: 1948542
    [No Abstract] [Full Text] [Related]

  • 6. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM, Ludlam CA.
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitors in young boys with haemophilia.
    Lusher JM.
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
    [Abstract] [Full Text] [Related]

  • 8. Hemophilia treatment. Side effects during immune tolerance induction.
    Brackmann HH, Schwaab R, Effenberger W, Hess L, Hanfland P, Oldenburg J.
    Haematologica; 2000 Oct; 85(10 Suppl):75-7. PubMed ID: 11187878
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution.
    Smith MP, Spence KJ, Waters EL, Beresford-Webb R, Mitchell MJ, Cuttler J, Alhaq A, Brown SA, Savidge GF.
    Thromb Haemost; 1999 Jan; 81(1):35-8. PubMed ID: 9974371
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T, Skopál J, Csáki C, Laczkó M, Schuler D, Borsi J.
    Orv Hetil; 1993 Dec 26; 134(52):2873-5. PubMed ID: 8272354
    [Abstract] [Full Text] [Related]

  • 17. Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patients.
    Landolfi R, de Cristofaro R, Lazzareschi I, Riccardi R, Mariani G.
    Haematologica; 2000 Oct 26; 85(10 Suppl):73-4. PubMed ID: 11187877
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.